Balaji Amines Ltd

Balaji Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Amines Ltd

₹ 1,242 -2.29%
12 Mar 4:01 p.m.
balajiamines.com BSE: 530999 NSE: BALAMINES
About

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]

Key Points

Market Leadership
The company is the largest manufacturer of aliphatic amines and their derivatives in India and the sole producer of a few specialty chemicals. [1]

Website BSE NSE
  • Market Cap ₹ 4,026 Cr.
  • Current Price ₹ 1,242
  • High / Low ₹ 2,550 / 1,230
  • Stock P/E 22.5
  • Book Value ₹ 488
  • Dividend Yield 0.88 %
  • ROCE 15.9 %
  • ROE 11.6 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 7.06% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of Nifty 500 Nifty MidSmallcap 400 Nifty 500 Multicap 50:25:25 Nifty Total Market Nifty Smallcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
472 622 515 451 413 347 337 325 308 367 333 320 299
368 495 385 363 357 292 286 277 250 278 274 262 248
Operating Profit 104 127 130 88 56 55 52 48 58 89 59 58 52
OPM % 22% 20% 25% 19% 14% 16% 15% 15% 19% 24% 18% 18% 17%
5 4 3 1 2 4 4 5 6 6 5 6 5
Interest 2 3 1 0 1 0 0 1 1 1 0 1 0
Depreciation 7 7 7 7 9 8 8 8 8 9 9 9 10
Profit before tax 100 121 124 81 49 51 47 44 56 85 55 54 47
Tax % 25% 32% 25% 25% 26% 26% 27% 26% 25% 26% 26% 26% 24%
75 82 93 61 36 38 34 33 42 63 41 40 36
EPS in Rs 23.10 25.21 28.60 18.74 11.24 11.64 10.64 10.09 12.82 19.32 12.51 12.47 11.02
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
509 608 602 632 665 858 947 918 1,227 1,914 1,720 1,332 1,319
429 517 500 503 513 676 753 738 901 1,473 1,391 1,086 1,062
Operating Profit 80 91 102 129 151 182 193 180 327 441 330 247 257
OPM % 16% 15% 17% 20% 23% 21% 20% 20% 27% 23% 19% 19% 20%
4 3 3 2 9 12 5 10 12 18 10 21 23
Interest 25 32 31 20 12 9 13 12 5 7 3 2 2
Depreciation 13 16 19 18 18 19 20 24 23 29 31 34 37
Profit before tax 46 46 56 93 130 166 166 154 310 423 305 232 241
Tax % 32% 27% 35% 34% 34% 32% 29% 26% 25% 27% 25% 26%
31 34 36 61 86 113 118 114 232 308 228 171 179
EPS in Rs 9.62 10.35 11.22 18.91 26.41 34.93 36.44 35.11 71.51 95.04 70.23 52.87 55.32
Dividend Payout % 14% 10% 11% 11% 8% 7% 8% 9% 6% 6% 14% 21%
Compounded Sales Growth
10 Years: 8%
5 Years: 7%
3 Years: 3%
TTM: 0%
Compounded Profit Growth
10 Years: 18%
5 Years: 8%
3 Years: -10%
TTM: 22%
Stock Price CAGR
10 Years: 31%
5 Years: 33%
3 Years: -24%
1 Year: -42%
Return on Equity
10 Years: 21%
5 Years: 20%
3 Years: 19%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 166 196 231 285 371 461 569 661 891 1,186 1,394 1,528 1,573
209 262 236 159 103 115 95 102 0 0 0 0 0
139 158 129 156 175 237 327 334 394 292 151 202 161
Total Liabilities 520 621 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,741
234 325 321 322 309 316 318 363 344 495 604 724 723
CWIP 63 8 3 16 25 66 63 46 173 141 74 143 214
Investments 21 21 30 30 30 66 66 114 66 66 128 66 66
203 268 249 238 292 371 550 581 708 782 745 803 738
Total Assets 520 621 603 607 655 819 997 1,104 1,292 1,484 1,551 1,736 1,741

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
94 111 60 84 72 126 89 148 94 176 187 170
-86 -50 -14 -30 -23 -93 -47 -130 -87 -142 -155 -144
-10 -53 -49 -52 -54 -29 -29 -31 3 -20 -22 -35
Net Cash Flow -2 7 -3 2 -5 4 13 -13 10 14 10 -8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 74 79 70 69 67 73 64 76 81 83 55 72
Inventory Days 66 87 93 62 88 70 100 66 56 69 97 127
Days Payable 42 83 46 57 55 56 58 40 43 57 13 35
Cash Conversion Cycle 99 83 117 74 100 87 106 102 94 95 139 163
Working Capital Days 75 67 85 58 67 71 82 87 80 80 98 118
ROCE % 19% 18% 19% 24% 30% 33% 29% 23% 38% 41% 24% 16%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
53.70% 53.70% 53.70% 53.70% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71%
3.99% 4.51% 4.55% 4.39% 4.45% 4.55% 4.52% 4.58% 4.92% 5.05% 5.27% 5.16%
0.16% 0.18% 0.24% 0.37% 0.34% 0.18% 0.90% 1.43% 1.48% 1.59% 1.79% 1.66%
42.15% 41.61% 41.51% 41.53% 41.50% 41.57% 40.88% 40.31% 39.91% 39.67% 39.23% 39.46%
No. of Shareholders 1,21,0441,19,6511,20,7851,29,7021,36,6441,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,361

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls